Mass spectrometry, a powerful tool for studying tiny molecules, has long helped scientists unlock secrets hidden in plants, ...

"Hevin is a well-known molecule involved in neural plasticity ... With this information and using a recombinant viral vector, the group at the UFRJ Institute of Biomedical Sciences overexpressed ...

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform ...

Malaria remains a persistent public health burden, with Plasmodium falciparum causing the most dangerous form of malaria and ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

In the last week, the market has stayed flat, but it is up 11% over the past year, with earnings expected to grow by 14% per annum over the next few years. Though the term 'penny stock' might sound ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Scientists say they've put together a molecular toolkit that could be used to treat a variety of brain diseases, possibly ...

EMERYVILLE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...